Profound Muscle Weakness and Pain after One Dose of Actonel
Joint Authors
Badayan, Irina
Cudkowicz, Merit E.
Source
Issue
Vol. 2009, Issue 2009 (31 Dec. 2009), pp.1-3, 3 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2009-10-11
Country of Publication
Egypt
No. of Pages
3
Main Subjects
Abstract EN
The World Health Organization (WHO) defines osteopenia as a bone density between 1 and 2.5 standard deviation (SD) below the bone density of a normal young adult Iqbal 2000.
Osteoporosis is defined as 2.5 SD or more below that reference point Iqbal 2000.
Bisphosphonates are a group of medications used to treat osteoporosis, Padget's disease of bone, and osteopenia.
We report a woman who developed profound muscle weakness and pain after one dose of Risedronate (Actonel).
American Psychological Association (APA)
Badayan, Irina& Cudkowicz, Merit E.. 2009. Profound Muscle Weakness and Pain after One Dose of Actonel. Case Reports in Medicine،Vol. 2009, no. 2009, pp.1-3.
https://search.emarefa.net/detail/BIM-491065
Modern Language Association (MLA)
Badayan, Irina& Cudkowicz, Merit E.. Profound Muscle Weakness and Pain after One Dose of Actonel. Case Reports in Medicine No. 2009 (2009), pp.1-3.
https://search.emarefa.net/detail/BIM-491065
American Medical Association (AMA)
Badayan, Irina& Cudkowicz, Merit E.. Profound Muscle Weakness and Pain after One Dose of Actonel. Case Reports in Medicine. 2009. Vol. 2009, no. 2009, pp.1-3.
https://search.emarefa.net/detail/BIM-491065
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-491065
